• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Overexpression of EVI1 interferes with cytokinesis and leads to accumulation of cells with supernumerary centrosomes in G0/1 phase.EVI1 的过表达干扰胞质分裂,导致 G0/G1 期具有过多中心体的细胞积累。
Cell Cycle. 2012 Sep 15;11(18):3492-503. doi: 10.4161/cc.21801. Epub 2012 Aug 16.
2
Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest.中心体完整性的丧失会诱导p38-p53-p21依赖性的G1-S期阻滞。
Nat Cell Biol. 2007 Feb;9(2):160-70. doi: 10.1038/ncb1529.
3
FLJ25439, a novel cytokinesis-associated protein, induces tetraploidization and maintains chromosomal stability via enhancing expression of endoplasmic reticulum stress chaperones.FLJ25439,一种新型的胞质分裂相关蛋白,通过增强内质网应激伴侣蛋白的表达诱导四倍体化并维持染色体稳定性。
Cell Cycle. 2015;14(8):1174-87. doi: 10.1080/15384101.2015.1010906.
4
EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells.EVI1 通过上调人髓细胞中的 CDKN1A/p21/WAF 抑制抗白血病药物诱导的细胞凋亡。
PLoS One. 2013;8(2):e56308. doi: 10.1371/journal.pone.0056308. Epub 2013 Feb 14.
5
New functions for ecotropic viral integration site 1 (EVI1), an oncogene causing aggressive malignant disease.嗜亲性病毒整合位点1(EVI1)的新功能,EVI1是一种可引发侵袭性恶性疾病的致癌基因。
Cell Cycle. 2012 Nov 1;11(21):3915. doi: 10.4161/cc.22392. Epub 2012 Oct 3.
6
Mammalian cells lack checkpoints for tetraploidy, aberrant centrosome number, and cytokinesis failure.哺乳动物细胞缺乏针对四倍体、异常中心体数量和胞质分裂失败的检查点。
BMC Cell Biol. 2005 Feb 15;6(1):6. doi: 10.1186/1471-2121-6-6.
7
EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.EVI1 靶向 ΔNp63 并上调细胞周期蛋白依赖性激酶抑制剂 p21,而不依赖于 p53,以延缓结肠癌细胞的细胞周期进程和增殖。
Int J Biochem Cell Biol. 2013 Aug;45(8):1568-76. doi: 10.1016/j.biocel.2013.04.032. Epub 2013 May 9.
8
Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest.细胞周期蛋白G2是一种与中心体相关的核质穿梭蛋白,它影响微管稳定性并诱导p53依赖的细胞周期停滞。
Exp Cell Res. 2006 Dec 10;312(20):4181-204. doi: 10.1016/j.yexcr.2006.09.023. Epub 2006 Sep 29.
9
Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.在慢性髓性白血病的髓系原始细胞危象中,LEF1/β-连环蛋白复合物通过p53改变激活EVI1转录。
Biochem Biophys Res Commun. 2017 Jan 22;482(4):994-1000. doi: 10.1016/j.bbrc.2016.11.146. Epub 2016 Nov 28.
10
p53 deficiency exacerbates pleiotropic mitotic defects, changes in nuclearity and polyploidy in transdifferentiating pancreatic acinar cells.p53基因缺陷会加剧胰腺腺泡细胞转分化过程中多向性有丝分裂缺陷、核型变化及多倍体形成。
Oncogene. 2005 Mar 24;24(13):2184-94. doi: 10.1038/sj.onc.1208249.

引用本文的文献

1
MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma.MECOM/PRDM3和PRDM16作为预后相关生物标志物,与肺腺癌中的免疫细胞浸润相关。
Front Oncol. 2022 Jan 31;12:772686. doi: 10.3389/fonc.2022.772686. eCollection 2022.
2
Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.中心体扩增:实体恶性肿瘤中具有预后价值的可量化癌细胞特征。
Cancer Metastasis Rev. 2021 Mar;40(1):319-339. doi: 10.1007/s10555-020-09937-z. Epub 2020 Oct 26.
3
EVI1 in Leukemia and Solid Tumors.白血病和实体瘤中的EVI1
Cancers (Basel). 2020 Sep 18;12(9):2667. doi: 10.3390/cancers12092667.
4
Cytokinesis arrest and multiple centrosomes in B cell chronic lymphocytic leukaemia.B 细胞慢性淋巴细胞白血病中的细胞有丝分裂阻滞和多个中心体。
J Cell Mol Med. 2018 May;22(5):2846-2855. doi: 10.1111/jcmm.13579. Epub 2018 Mar 7.
5
Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.MECOM 基因的 EVI1 和 EVI1Δ324 异构体在全基因组转录调控和致癌性中的功能特征。
Oncogene. 2016 May 5;35(18):2311-21. doi: 10.1038/onc.2015.286. Epub 2015 Aug 3.
6
EVI1 promotes tumor growth via transcriptional repression of MS4A3.EVI1通过对MS4A3的转录抑制来促进肿瘤生长。
J Hematol Oncol. 2015 Mar 21;8:28. doi: 10.1186/s13045-015-0124-6.
7
The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid.致癌基因EVI1增强人髓细胞对全反式维甲酸的转录和生物学反应。
Cell Cycle. 2014;13(18):2931-43. doi: 10.4161/15384101.2014.946869.
8
Induction of Chromosomal Instability via Telomere Dysfunction and Epigenetic Alterations in Myeloid Neoplasia.诱导骨髓增生异常肿瘤中端粒功能障碍和表观遗传改变引起的染色体不稳定性。
Cancers (Basel). 2013 Jul 4;5(3):857-74. doi: 10.3390/cancers5030857.
9
EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells.EVI1 通过上调人髓细胞中的 CDKN1A/p21/WAF 抑制抗白血病药物诱导的细胞凋亡。
PLoS One. 2013;8(2):e56308. doi: 10.1371/journal.pone.0056308. Epub 2013 Feb 14.
10
EVI1 and MDS1/EVI1 expression during primary human hematopoietic progenitor cell differentiation into various myeloid lineages.EVI1 和 MDS1/EVI1 在原代人造血祖细胞向各种髓系谱系分化过程中的表达。
Anticancer Res. 2012 Nov;32(11):4883-9.

本文引用的文献

1
DNA damage-induced centrosome amplification occurs via excessive formation of centriolar satellites.DNA 损伤诱导的中心体扩增是通过中心粒卫星的过度形成发生的。
Oncogene. 2013 Jun 13;32(24):2963-72. doi: 10.1038/onc.2012.310. Epub 2012 Jul 23.
2
STIL is required for centriole duplication in human cells.STIL 对于人类细胞的中心体复制是必需的。
J Cell Sci. 2012 Mar 1;125(Pt 5):1353-62. doi: 10.1242/jcs.104109. Epub 2012 Feb 20.
3
Cep63 recruits Cdk1 to the centrosome: implications for regulation of mitotic entry, centrosome amplification, and genome maintenance.Cep63 将 Cdk1 招募到中心体:对有丝分裂进入、中心体扩增和基因组维护的调节意义。
Cancer Res. 2011 Mar 15;71(6):2129-39. doi: 10.1158/0008-5472.CAN-10-2684.
4
DSas-6 and Ana2 coassemble into tubules to promote centriole duplication and engagement.DSas-6 和 Ana2 共组装形成小管,以促进中心体复制和衔接。
Dev Cell. 2010 Dec 14;19(6):913-9. doi: 10.1016/j.devcel.2010.11.010.
5
Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.急性髓系白血病中 WHO 类型 inv(3)(q21q26.2)/t(3;3)(q21;q26.2) 和其他各种 3q 异常的临床、分子和预后意义。
J Clin Oncol. 2010 Aug 20;28(24):3890-8. doi: 10.1200/JCO.2010.29.2771. Epub 2010 Jul 26.
6
Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience.年轻成人和老年急性髓系白血病中单倍体核型的预后影响:西南肿瘤协作组(SWOG)的经验。
Blood. 2010 Sep 30;116(13):2224-8. doi: 10.1182/blood-2010-02-270330. Epub 2010 Jun 18.
7
High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.EVI1 高表达可预测年轻成人急性髓系白血病患者的预后,并与独特的细胞遗传学异常相关。
J Clin Oncol. 2010 Apr 20;28(12):2101-7. doi: 10.1200/JCO.2009.26.0646. Epub 2010 Mar 22.
8
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.基因治疗慢性肉芽肿病后 EVI1 激活导致基因组不稳定和 7 号单体性骨髓增生异常。
Nat Med. 2010 Feb;16(2):198-204. doi: 10.1038/nm.2088. Epub 2010 Jan 24.
9
Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group.染色体不稳定性与骨髓增生异常综合征患者的不良预后相关,与细胞遗传学危险分组无关。
J Cell Mol Med. 2010 Apr;14(4):895-902. doi: 10.1111/j.1582-4934.2009.00905.x. Epub 2009 Sep 14.
10
Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes.EVI1在人髓系细胞中的可诱导表达导致的表型与其在骨髓增生异常综合征中的作用一致。
J Leukoc Biol. 2009 Oct;86(4):813-22. doi: 10.1189/jlb.0109042. Epub 2009 Jul 15.

EVI1 的过表达干扰胞质分裂,导致 G0/G1 期具有过多中心体的细胞积累。

Overexpression of EVI1 interferes with cytokinesis and leads to accumulation of cells with supernumerary centrosomes in G0/1 phase.

机构信息

Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg; Heidelberg, Germany.

出版信息

Cell Cycle. 2012 Sep 15;11(18):3492-503. doi: 10.4161/cc.21801. Epub 2012 Aug 16.

DOI:10.4161/cc.21801
PMID:22894935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3467026/
Abstract

Ectopic viral integration site 1 (EVI1), a transcription factor frequently overexpressed in myeloid neoplasias, has been implicated in the generation of malignancy-associated centrosomal aberrations and chromosomal instability. Here, we sought to investigate the underlying cause of centrosome amplification in EVI1-overexpressing cells. We found that overexpression of EVI1-HA in U2OS cells induced supernumerary centrosomes, which were consistently associated with enlarged nuclei or binuclear cells. Live cell imaging experiments identified cytokinesis failure as the underlying cause of this phenotype. In accordance with previous reports, EVI1 overexpression induced a partial cell cycle arrest in G0/1 phase, accompanied by elevated cyclin D1 and p21 levels, reduced Cdk2 activity and activation of the p53 pathway. Supernumerary centrosomes predominantly occurred in resting cells, as identified by low levels of the proliferation marker Ki-67, leading to the conclusion that they result from tetraploidization after cytokinesis failure and are confined to G0/1-arrested tetraploid cells. Depletion of p53 using siRNA revealed that further polyploidization of these cells was inhibited by the p53-dependent tetraploidy checkpoint.

摘要

异位病毒整合位点 1(EVI1)是一种在髓系肿瘤中经常过表达的转录因子,它与致瘤性中心体异常和染色体不稳定性的产生有关。在这里,我们试图研究 EVI1 过表达细胞中中心体扩增的潜在原因。我们发现,EVI1-HA 在 U2OS 细胞中的过表达诱导了多余的中心体,这些中心体始终与增大的核或双核细胞相关。活细胞成像实验确定有丝分裂失败是这种表型的潜在原因。与先前的报道一致,EVI1 过表达诱导了 G0/1 期的部分细胞周期阻滞,伴随着细胞周期蛋白 D1 和 p21 水平的升高,Cdk2 活性的降低和 p53 途径的激活。多余的中心体主要发生在静止的细胞中,这是通过增殖标志物 Ki-67 的低水平来确定的,这导致了它们是有丝分裂失败后四倍体化的结果,并局限于 G0/1 期阻滞的四倍体细胞的结论。使用 siRNA 耗尽 p53 表明,这些细胞的进一步多倍化被 p53 依赖性四倍体检查点所抑制。